Phosphodiesterase 3/4 Inhibitor Zardaverine Exhibits Potent and Selective Antitumor Activity against Hepatocellular Carcinoma Both In Vitro and In Vivo Independently of Phosphodiesterase Inhibition
Liping Sun(Yangzhou University), Liguang Lou(Shanghai Institute of Materia Medica), Youhong Hu(Chinese Academy of Sciences), Lei Wang(Guangzhou University of Chinese Medicine), Chengying Xie(CNH Industrial (Czechia)), Haitian Quan(Chinese Academy of Sciences)
Cited by 28
Related Papers
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity <i>in vitro</i> and <i>in vivo</i>
|Cancer Science|2011|519
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor
|Cancer Science|2018|368
ZmLEA3, a Multifunctional Group 3 LEA Protein from Maize (Zea mays L.), is Involved in Biotic and Abiotic Stresses
|Plant and Cell Physiology|2013|216